PRIMARY STUDY

Rowatinex for the treatment of ureterolithiasis

Key Findings:  Despite the larger average diameter of calculi in the group of patients treated with Rowatinex, the overall stone expulsion rate was significantly higher in the Rowatinex group as compared to placebo.

Type of Study:  Double Blind Clinical Trial

Study Sample Size:  87

Study Result:  Positive

Study Location(s):  Israel

Year of Pub:  1992


Cannabinoids Studied: 

Phytocannabinoid Source:  Not Applicable

Terpenes Studied:  Borneol, Eucalyptol, Pinene

Route of Administration:  Oral (Ingestion)



Link to study